🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We aim to analyze whether the "liquid biopsy" model could increase the spec...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04079699
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199
Pilot study on patients with invasive ductal breast cancer triple negative ...
Status
Unknown
Location
European Instituto of Oncology
Start Date
2018-06-01
Trial ID
NCT04365803
Treatments Being Tested
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare condition ...
Status
Unknown
Location
Aberdeen Royal Infirmary
Start Date
2015-08
Trial ID
NCT02989480
Treatments Being Tested
The aim is to evaluate EUS-FNA efficacy for AIP diagnosis using a 22-gauge ...
Status
Completed
Location
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2013-01
Trial ID
NCT03241797
Treatments Being Tested
This is a prospective observational study that will follow patients who und...
Status
Recruiting
Location
Zuckerberg San Francisco General Hospital and Trauma Center
Start Date
2017-12-17
Trial ID
NCT03774758
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
Routine clinical and radiological assessment of response of patients with r...
Status
Active Not Recruiting
Location
CHU Bordeaux
Start Date
2021-09-21
Trial ID
NCT04852653
Treatments Being Tested
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692